Table 1 Details of the studies included and the number of samples with each disease subtype.
AITL | ATLL | EATL | HSTL | MF | NKTCL | PTCL | SS | ||
|---|---|---|---|---|---|---|---|---|---|
Choi 201516 | – | – | – | – | – | – | – | 33 | 33 |
da Silva Almeida 201517 | – | – | – | – | 8 | – | – | 26 | 34 |
Jiang 201512 | – | – | – | – | – | 25 | – | – | 25 |
Kataoka 201511 | – | 81 | – | – | – | – | – | – | 81 |
McKinney 201713 | – | – | – | 64 | – | – | – | – | 64 |
Moffitt 201714 | – | – | 58 | – | – | – | – | – | 58 |
Palomero 201418 | 3 | – | 1 | – | – | 2 | 6 | – | 12 |
Prasad 201619 | – | – | – | – | – | – | – | 12 | 12 |
Roberti 201620 | – | – | 15 | – | – | – | – | – | 15 |
Sakata–Yanagimoto 201421 | 3 | – | – | – | – | – | 3 | – | 6 |
Ungewickell 201522 | – | – | – | – | 6 | – | – | 5 | 11 |
Wang 201523 | – | – | – | – | – | – | – | 37 | 37 |
Woollard 201624 | – | – | – | – | – | – | – | 10 | 10 |
Yoo 201425 | 5 | – | – | – | – | – | – | – | 5 |
11 | 81 | 74 | 64 | 14 | 27 | 9 | 123 |